Copyright
©The Author(s) 2023.
World J Cardiol. Sep 26, 2023; 15(9): 427-438
Published online Sep 26, 2023. doi: 10.4330/wjc.v15.i9.427
Published online Sep 26, 2023. doi: 10.4330/wjc.v15.i9.427
Table 5 Logistic regression on predictors of increased troponin elevation
| B | SE | Wald | df | Sig | Exp (B) | 95%CI for EXP (B) | ||
| Lower | Upper | |||||||
| Lactate dehydrogenase | 0.000 | 0.000 | 8.091 | 1 | 0.004 | 1.000 | 1.000 | 1.001 |
| Congestive heart failure | 0.991 | 0.239 | 17.170 | 1 | 0.000 | 2.694 | 1.686 | 4.305 |
| Intensive care unit | 1.278 | 0.232 | 30.359 | 1 | 0.000 | 3.591 | 2.279 | 5.659 |
| Constant | -3.154 | 0.194 | 264.436 | 1 | 0.000 | 0.043 | ||
- Citation: Umeh CA, Maoz H, Obi J, Dakoria R, Patel S, Maity G, Barve P. Remdesivir, dexamethasone and angiotensin-converting enzyme inhibitors use and mortality outcomes in COVID-19 patients with concomitant troponin elevation. World J Cardiol 2023; 15(9): 427-438
- URL: https://www.wjgnet.com/1949-8462/full/v15/i9/427.htm
- DOI: https://dx.doi.org/10.4330/wjc.v15.i9.427